Luzindole

CAS No. 117946-91-5

Luzindole ( N-0774 )

Catalog No. M23346 CAS No. 117946-91-5

Luzindole is a selective melatonin receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 132 In Stock
10MG 224 In Stock
25MG 377 In Stock
50MG 556 In Stock
100MG 788 In Stock
500MG 1575 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Luzindole
  • Note
    Research use only, not for human use.
  • Brief Description
    Luzindole is a selective melatonin receptor antagonist.
  • Description
    Luzindole is a selective melatonin receptor antagonist. Luzindole inhibits experimental autoimmune encephalomyelitis and exerts antidepressant-like activity. Luzindole preferentially targets MT2 (Mel1b) over MT1 (Mel1a) with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively.
  • Synonyms
    N-0774
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    MT1 receptor;MT2 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    117946-91-5
  • Formula Weight
    292.4
  • Molecular Formula
    C19H20N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (342.03 mM; Need ultrasonic)
  • SMILES
    CC(NCCc1c(Cc2ccccc2)[nH]c2c1cccc2)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dubocovich ML, et al. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):365-75.
molnova catalog
related products
  • Corydaline

    Corydaline, an isoquinoline alkaloid, is one of the major active constituents in a new prokinetic botanical agent.

  • sodium 3-amino-4,6-d...

    sodium 3-amino-4,6-dimethylthieno[2,3-b]pyridine-2-carboxylate is a chemical compound.

  • PTC299

    PTC299 (PTC-299) is a novel potent inhibitor of dihydroorotate dehydrogenase (DHODH), inhibits hypoxia-induced VEGFA protein production in HeLa cells with IC50 of 1.64 nM.